Abcellera Biologics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ABCL and other ETFs, options, and stocks.

About ABCL

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. 

CEO
Carl Lars G. Hansen
CEOCarl Lars G. Hansen
Employees
586
Employees586
Headquarters
Vancouver, British Columbia
HeadquartersVancouver, British Columbia
Founded
2012
Founded2012
Employees
586
Employees586

ABCL Key Statistics

Market cap
1.14B
Market cap1.14B
Price-Earnings ratio
-7.70
Price-Earnings ratio-7.70
Dividend yield
—
Dividend yield—
Average volume
1.18M
Average volume1.18M
High today
$4.25
High today$4.25
Low today
$3.89
Low today$3.89
Open price
$4.01
Open price$4.01
Volume
1.60M
Volume1.60M
52 Week high
$8.05
52 Week high$8.05
52 Week low
$3.79
52 Week low$3.79

ABCL News

Simply Wall St 3d
In the wake of AbCellera Biologics Inc.'s latest US$91m market cap drop, institutional owners may be ... - Simply Wall St

Key Insights Significantly high institutional ownership implies AbCellera Biologics' stock price is sensitive to their trading actions 50% of the business is...

In the wake of AbCellera Biologics Inc.'s latest US$91m market cap drop, institutional owners may be ... - Simply Wall St

Analyst ratings

100%

of 9 ratings
Buy
100%
Hold
0%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.